| P50 | author | Ayman El-Menyar | Q50057678 |
| P2093 | author name string | Hassan Al-Thani | |
| | Mohammad Asim | |
| P2860 | cites work | Epidemiology of cancer-associated venous thrombosis | Q38125997 |
| | Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism | Q38169675 |
| | One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events | Q39428208 |
| | Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study | Q40928535 |
| | Analysis of risk factors for recurrence of deep venous thrombosis in lower extremities | Q41969185 |
| | Hospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready? | Q42557127 |
| | Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries | Q44442179 |
| | Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. | Q44446974 |
| | The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms | Q46565501 |
| | High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. | Q51127047 |
| | Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. | Q51574600 |
| | Risk factors for venous thromboembolism | Q73548120 |
| | Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors | Q73592975 |
| | The anatomy of deep venous thrombosis of the lower extremity | Q73777030 |
| | Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis | Q77932767 |
| | Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24633053 |
| | Assessing the risk of recurrent venous thromboembolism--a practical approach | Q26796430 |
| | Recurrent venous thromboembolism: what is the risk and how to prevent it | Q26826847 |
| | Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation | Q28074457 |
| | Guidance for the treatment of deep vein thrombosis and pulmonary embolism | Q28078989 |
| | The epidemiology of venous thromboembolism in the community | Q33865646 |
| | Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study | Q33895888 |
| | Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease | Q33904210 |
| | Risk assessment for recurrent venous thrombosis | Q34153343 |
| | Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis | Q34603112 |
| | Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q34788523 |
| | Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. | Q35486931 |
| | Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study | Q35525678 |
| | Diagnosis of lower-extremity deep vein thrombosis in outpatients. | Q35850367 |
| | Venous thromboembolism in patients with diabetes mellitus | Q36178744 |
| | Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality | Q36534259 |
| | Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. | Q36550717 |
| | Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study | Q36733711 |
| | Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis | Q37176001 |
| | Epidemiology of recurrent venous thrombosis | Q37370722 |
| | The role of ethnicity, age and gender in venous thromboembolism | Q37523338 |
| | Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism | Q37741638 |
| | Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review | Q37849816 |
| | The coagulopathy of chronic liver disease | Q37900633 |
| | Venous thrombosis: understanding the paradoxes of recurrence | Q38117733 |
| P921 | main subject | venous thromboembolism | Q9397786 |
| | thrombosis | Q261327 |
| | deep vein thrombosis | Q1762339 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2391-2399 | |
| P577 | publication date | 2017-05-20 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience | |
| P478 | volume | 23 | |